UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | F | H | J | K | L | M | N | O | P | R | S | T | V | W
Number of items: 80.

A

Aballea, S; Chancellor, JVM; Raikou, M; Drummond, MF; Weinstein, MC; Jourdan, S; Bridgewater, J; (2007) Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US. CANCER , 109 (6) pp. 1082-1089. 10.1002/cncr.22512.

Ah-See, M-L.W.; (2007) Evaluation of the vascular response to neoadjuvant chemotherapy in primary breast cancer. Doctoral thesis , University of London. Green open access
file

Alonzi, R; Padhani, AR; Taylor, NJ; Stirling, JJ; Saunders, MI; Hoskin, PJ; (2007) Physiological changes within the prostate caused by androgen withdrawal. In: (pp. S6-S6).

Arkenau, H-T; Chua, YJ; Cunningham, D; (2007) Current treatment strategies in elderly patients with metastatic colorectal cancer. CLINICAL COLORECTAL CANCER , 6 (7) pp. 508-515. 10.3816/CCC.2007.n.016.

Arkenau, H-T; Gordon, C; Cunningham, D; Norman, A; Wotherspoon, A; Chau, I; (2007) Mucosa associated lymphoid tissue lymphoma of the lung: The Royal Marsden Hospital experience. LEUKEMIA & LYMPHOMA , 48 (3) pp. 547-550. 10.1080/10428190601094388.

B

Bajwa, A; Blunt, N; Vyas, S; McKenzie, G; Bridgewater, J; Hochhauser, D; Obichere, A; (2007) Predictive factors of outcome in patients with asymptomatic stage IV colorectal cancer and irresectable liver metastases. In: (pp. V1170-V1170).

Begent, RH; (2007) Interpretation of treatment results with biological agents: is there a need for a new methodology? J BUON , 12 Sup S53-S58.

Begent, RHJ; Sharma, SK; Mayer, A; Tolner, B; Pedley, RB; Wilkins, D; Kogelberg, H; (2007) Incorporating single chain Fv antibodies into therapeutic proteins: issues exemplified in antibody-directed enzyme prodrug therapy (ADEPT). In: IMMUNOLOGY. (pp. 42 - 42). BLACKWELL PUBLISHING

Beresford, M; Lyburn, I; Sanghera, B; Makris, A; Wong, WL; (2007) Serial integrated F-18-fluorodeoxythymidine PET/CT monitoring neoadjuvant chemotherapeutic response in invasive ductal carcinoma. BLACKWELL PUBLISHING

Beresford, MJ; Ravichandran, D; Makris, A; (2007) Neoadjuvant endocrine therapy in breast cancer. Cancer Treatment Reviews , 33 (1) pp. 48-57.

Boone, J.J.M.; (2007) The role of ErbB2 and BRCA1 in repair of drug-induced DNA damage. Doctoral thesis , University of London. Green open access
file

Burdak-Rothkamm, S; Short, S; Folkard, M; Rothkamm, K; Prise, KM; (2007) ATR-Dependent Radiation Induced g-H2AX Foci In Bystander Primary Human Astrocytes And Glioma Cells. Oncogene , 26 (7) pp. 993-1002. 10.1038/sj.onc.1209863.

C

Chong, IY; Hoskin, PJ; (2007) Vaginal vault brachytherapy for low risk endometrial carcinoma. In: (pp. S8-S8).

Chowdhury, T.; (2007) Investigation of the role of MLL-ENL in leukaemogenesis. Doctoral thesis , University of London. Green open access
file

Clingen, PH; Arlett, CF; Hartley, JA; Parris, CN; (2007) Chemosensitivity of primary human fibroblasts with defective unhooking of DNA interstrand cross-links. EXP CELL RES , 313 (4) 753 - 760. 10.1016/j.yexcr.2006.11.007.

D

Dancey, G; Violet, J; Othman, S; Parker, S; Green, A; Sharma, S; Francis, R; ... McNamara, C; + view all (2007) Phase I trial of the I-131-labelled Anti-CD25 antibody basiliximab in the treatment of patients with relapsed or refractory lymphoma. In: BLOOD. (pp. 199A - 200A). AMER SOC HEMATOLOGY

Dearling, JLJ; Qureshi, U; Begent, RHJ; Pedley, RB; (2007) Combining radioimmunotherapy with antihypoxia therapy 2-deoxy-D-glucose results in reduction of therapeutic efficacy. CLIN CANCER RES , 13 (6) 1903 - 1910. 10.1158/1078-0432.CCR-06-2094.

Diez, P; Hoskin, PJ; (2007) Conventional and CT-based volumes in IFRT for supradiaphragmatic malignant lymphoma. In: (pp. S16-S16).

F

Fox, J; Glasspool, D; Grecu, D; Modgil, S; South, M; Patkar, V; (2007) Argumentation-based inference and decision making - A medical perspective. IEEE INTELL SYST , 22 (6) 34 - 41.

H

Hochhauser, D; Kotecha, M; O'Hare, C; Morris, PJ; Hartley, JM; Taherbhai, Z; Harris, D; ... Hartley, JA; + view all (2007) Modulation of topoisomerase II expression in mammalian cells with a sequence-specific polyamide. Molecular Cancer Therapeutics , 6 (1) pp. 346-354.

Hoskin, PJ; Bownes, P; Bryant, L; Ostler, P; (2007) HDR monotherapy brachytherapy for localised prostate cancer. In: (pp. S7-S7).

Hoskin, PJ; Carnell, DM; Taylor, NJ; Smith, RE; Stirling, JJ; Daley, FM; Saunders, MI; ... Padhani, AP; + view all (2007) Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY , 68 (4) pp. 1065-1071.

Hoskin, PJ; Dearnaley, DP; (2007) Hypofractionation in clinical trials for prostate cancer. ELSEVIER SCIENCE LONDON

Hoskin, PJ; Motohashi, K; Bownes, P; Bryant, L; Ostler, P; (2007) High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial. Radiotherapy & Oncology , 84 (2) pp. 114-120.

Hoskin, PJ; Venselaar, J; (2007) Prostate brachytherapy in Europe: Growth, practice and guidelines. UNSPECIFIED

Howie, AJ; (2007) The association among C4d staining in renal transplant biopsies, the production of donor-specific HLA antibodies, and graft outcome. Transplantation , 83 (4) pp. 373-374. 10.1097/01.tp.0000251424.65487.5c.

Huddart, RA; O'Doherty, MJ; Padhani, A; Rustin, GJ; Mead, GM; Joffe, JK; Vasey, P; ... Stenning, SPNCRITTCSG; + view all (2007) 18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group. Clinical Oncology , 25 (11) pp. 1310-1315.

J

Jain, P; Cerone, MA; Leblanc, AC; Autexier, C; (2007) Telomerase and neuronal marker status of differentiated NT2 and SK-N-SH human neuronal cells and primary human neurons. J Neurosci Res , 85 (1) pp. 83-89. 10.1002/jnr.21094.

Ji, H; Rintelen, F; Waltzinger, C; BertschyMeier, D; Pearce, W; Hirsch, E; Wymman, M; ... Rommel, C; + view all (2007) Inactivation of PI3Kg and PI3Kd distorts T cell development and renders susceptibility to multiple organ inflammation. INFLAMMATION RESEARCH , 56 S444-S444.

Jim, JH; Dhami, P; King, A; Cooper, J; Vetrie, D; (2007) Identification of target genes of an erythroid transcription factor complex containing SCL (TAL1). In: BLOOD. (pp. 85B - 86B). AMER SOC HEMATOLOGY

Joerger, M; Huitema, ADR; Richel, DJ; Dittrich, C; Pavlidis, N; Briasoulis, E; Vermorken, JB; ... Schellens, JHM; + view all (2007) Population PKPD of paclitaxel and carboplatin in ovarian cancer patients: A study by the EORTC-PAMM-NDDG. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , 63 (4) 505 - 505.

Jones, AM; Thirlwell, C; Howarth, KM; Graham, T; Chambers, W; Segditsas, S; Page, KM; ... Tomlinson, IPM; + view all (2007) Analysis of copy number changes suggests chromosomal instability in a minority of large colorectal adenomas. J PATHOL , 213 (3) 249 - 256. 10.1002/path.2234.

Judith, D; (2007) CT scan plan to combat cancer. Sunday Herald

K

Kandola, S; Anyamene, N; Payne, H; Harland, S; (2007) Transdermal oestrogen therapy as a second-line hormonal intervention in prostate cancer: a bad experience. BJU INTERNATIONAL , 99 (1) pp. 53-55. 10.1111/j.1464-410X.2007.06543.x.

Kiakos, K.; (2007) Molecular and cellular pharmacology of novel chiral and achiral CC-1065/duocarmycin analogues. Doctoral thesis , University of London. Green open access
file

Kogelberg, H; Tolner, B; Sharma, SK; Lowdell, MW; Qureshi, U; Robson, M; Hillyer, T; (2007) Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy (vol 17, pg 36, 2007). GLYCOBIOLOGY , 17 (10) 1030 - 1030. 10.1093/glycob/cw1053.

Kogelberg, H; Tolner, B; Thomas, G; Di Cara, D; Ramesh, B; Sodha, S; Lowdell, M; ... Chester, K; + view all (2007) Generation of a single-chain Fv with binding specificity for the integrin, alpha v beta 6, by rational structure based antibody engineering – a promising agent for cancer therapy. In: (Proceedings) NCRI Cancer Conference Proceedings.

Koukourakis, MI; Bentzen, SM; Giatromanolaki, A; Wilson, GD; Daley, FM; Saunders, MI; Dische, S; ... Harris, AL; + view all (2007) Endogenous markers of two separate hypoxia response pathways (HIF2 alpha and CA9) predict radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. Journal of Clinical Oncology , 24 (5) pp. 727-735. 10.1200/jco.2005.02.7474.

L

Ladenstein, R; Whelan, J; Oberlin, O; Weston, C; Jurgens, H; (2007) Multivariate analysis based risk grouping of Ewing tumours (ET) with extra-pulmonary metastatic disease (EPMD): Final results from the Euro Ewing 99 study. In:

Lee, SM; Woll, PJ; James, LJ; Hatton, M; Ali, K; Spiro, SG; Ali, SR; (2007) A phase III randomised, double blind, placebo controlled trial of etoposide/carboplatin with or without thalidomide in advanced small cell lung cancer (SCLC). In: (Proceedings) Presidential Symposium. 12th World Conference on Lung Cancer, Seoul, Korea.. (pp. S306-S307). Journal of Thoracic Oncology

Lee, SM; Woll, PJ; Rudd, ; RM, ; Gower, NH; Ottensmeier, CH; Ali, K; ... Hackshaw, A; + view all (2007) A phase III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced non-small cell lung cancer (NSCLC). In: (Proceedings) Proffered Paper. 12th World Conference on Lung Cancer, Seoul, Korea.. (pp. S359-). Journal of Thoracic Oncology

Leedham, S; Thirlwell, C; Novelli, M; Tomlinson, I; Wright, N; (2007) Using somatic APC mutations as clonal markers to demonstrate polyclonality in colonic polyps. In: GASTROENTEROLOGY. (pp. A428 - A428). W B SAUNDERS CO-ELSEVIER INC

Leedham, SJ; Thirlwell, C; Hoare, J; Tomlinson, I; Wright, NA; (2007) Using somatic APC mutations as clonal markers in colonic polyps. In: GUT. (pp. A50 - A50). B M J PUBLISHING GROUP

Lewis, IJ; Nooij, MA; Whelan, J; Sydes, MR; Grimer, R; Hogendoorn, PCW; Memon, MA; ... Taminiau, AHM; + view all (2007) Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup. Journal of the National Cancer Institute , 99 (2) pp. 112-128.

Lowe, H; Tolner, B; Kogelberg, H; Begent, R; Robson, L; Taylorson, C; Chester, K; (2007) A novel human enzyme with a bis-chloro-phenol prodrug for Antibody Directed Enzyme Prodrug Therapy (ADEPT). In: (Proceedings) NCRI Cancer Conference Proceedings.

Lucy, M; (2007) Why I didn’t have any qualms about taking thalidomide. The Express 56-.

M

Mandeville, HC; Ng, Q; Milner, J; Taylor, NJ; Stirling, JJ; Padhani, AR; d'Arcy, AJ; ... Hoskin, PJ; + view all (2007) CA4P and external beam radiotherapy in prostate cancer with assessment of effect by DCE-MRI. In: (pp. S38-S38).

Marina, N; S Bielack, MS; M Bernstein, TB-B; S Smeland, AH; Whelan, J; (2007) International collaboration is feasible in trials for rare conditions: the EURAMOS experience. In: (pp. Abstract 2-).

Marsh, D; Vigor, K; Kogelberg, H; Tolner, B; Meyer, T; Begent, R; Chana, J; ... Chester, K; + view all (2007) Antibody targeted magnetic nanoparticles for cancer imaging and therapy. In: (Proceedings) NCRI Cancer Conference Proceedings.

Martins, C; Gunaratnam, M; Stuart, J; Makwana, V; Greciano, O; Reszka, AP; Kelland, LR; (2007) Structure-based design of benzylamino-acridine compounds as G-quadruplex DNA telomere targeting agents. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS , 17 (8) pp. 2293-2298. 10.1016/j.bmcl.2007.01.056.

Milroy, L-G; Zinzalla, G; Prencipe, G; Michel, P; Ley, SV; Gunaratnam, M; Beltran, M; (2007) Chemical variation of natural-product-like scaffolds: Design, synthesis, and biological activity of fused bicyclic acetal derivatives. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION , 46 (14) pp. 2493-2496. 10.1002/anie.200604688.

N

Ng, Q-S; Goh, V; Milner, J; Stratford, MR; Folkes, LK; Tozer, GM; Saunders, MI; (2007) Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study. The Lancet Oncology , 8 (2) pp. 111-118. 10.1016/S1470-2045(07)70001-3.

Ng, QS; Goh, V; Carnell, D; Meer, K; Padhani, AR; Saunders, MI; Hoskin, PJ; (2007) Tumor antivascular effects of radiotherapy combined with combretastatin A4 phosphate in human non-small-cell lung cancer. International Journal of Radiation Oncology Biology Physics , 67 (5) pp. 1375-1380.

Ng, QS; Goh, V; Milner, J; Padhani, AR; Saunders, MI; Hoskin, PJ; (2007) Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: In vivo whole tumor assessment using volumetric perfusion computed tomography. International Journal of Radiation Oncology Biology Physics , 67 (2) pp. 417-424.

O

Okkenhaug, K; Ali, K; Vanhaesebroeck, B; (2007) Antigen receptor signalling: a distinctive role for the p110 delta isoform of Pl3K. TRENDS IN IMMUNOLOGY , 28 (2) 80 - 87. 10.1016/j.it.12.007.

P

Penn, H; Howie, AJ; Kingdon, EJ; Bunn, CC; Stratton, RJ; Black, CM; Burns, A; (2007) Scleroderma renal crisis-patient characteristics and outcomes in 110 cases from a single centre. In: RHEUMATOLOGY. (pp. I4 - I5). OXFORD UNIV PRESS

Plummer, ER; Calvert, H; (2007) Targeting poly(ADP-ribose) polymerase: A two-armed strategy for cancer therapy. CLIN CANCER RES , 13 (21) 6252 - 6256. 10.1158/1078-0432.CCR-07-0617.

Plummer, R; Vida, L; Perrett, R; Spicer, J; Stopfer, P; Shahidi, M; Temple, G; ... de Bono, J; + view all (2007) A phase I and pharmacokinetic (PK) study of BIBW 2992, an oral irreversible dual EGFR/HER2 inhibitor. In: EJC SUPPLEMENTS. (pp. 108 - 108). PERGAMON-ELSEVIER SCIENCE LTD

Porschen, R; Arkenau, H-T; Kubicka, S; Greil, R; Seufferlein, T; Freier, W; Kretzschmar, A; ... Schmoll, H-J; + view all (2007) Comments on final report of the AIO colorectal cancer group study: Fluorouracil/oxaliplatin versus capecitabine/oxaliplatin - In reply. JOURNAL OF CLINICAL ONCOLOGY , 25 (31) pp. 5042-5043. 10.1200/JCO.2007.14.4386.

Prag, S; Parsons, M; Keppler, MD; Ameer-Beg, SM; Barber, P; Hunt, J; Beavil, AJ; ... Ng, T; + view all (2007) Activated ezrin promotes cell migration through recruitment of the GEF Dbl to lipid rafts and preferential downstream activation of Cdc42. Mol Biol Cell , 18 (8) pp. 2935-2948. 10.1091/mbc.E06-11-1031.

R

Rades, D; Veninga, T; Stalpers, LJA; Basic, H; Hoskin, PJ; Karstens, JH; Schild, SE; (2007) Improved posttreatment functional outcome is associated with better survival in patients irradiated for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys , 67 (5) pp. 1506-1509. 10.1016/j.ijrobp.2006.11.029.

S

Sainz-Pastor, N; Tolner, B; Robson, L; Parizek, P; Binz, K; Forrer, P; Begent, R; ... Chester, K; + view all (2007) Selection and evaluation of designed ankyrin repeat proteins (DARPins) reactive with carcinoembryonic antigen (CEA). In: (Proceedings) NCRI Cancer Conference Proceedings.

Sexton, J; Mackay, H; Brown, T; Kotecha, M; O'Hare, C; Kluza, J; Hochhauser, D; ... Lee, M; + view all (2007) MEDI 309-Regulation of the topoisomerase II alpha gene using polyamides that binds to the inverted CCAAT box present in the promoter. ABSTR PAP AM CHEM S , 234 ? - ?.

Short, SC; Martindale, C; Bourne, S; Brand, J; Johnston, P; (2007) DNA damage response in gliomas and normal human astrocytes. Neuro-Oncology , 9 (4) pp. 404-411.

Short, SC; Martindale, C; Bourne, SM; Brand, G; Woodcock, M; Johnston, P; (2007) Damage signalling after TMZ and radiation in glioma cells and sensitisation by inhibition of repair in G2. In:

Sky, NRSM; (2007) Thalidomide could get cancer treatment licence. UNSPECIFIED

Smith, AE; Pinkney, M; Piggott, NH; Calvert, H; Milton, ID; Lunec, J; (2007) Novel monoclonal antibody for detection of folate receptor alpha in paraffin-embedded tissues. HYBRIDOMA , 26 (5) 281 - 288. 10.1089/hyb.2007.0512.

Spicer, J; Calvert, H; Vidal, L; Azribi, F; Perrett, R; Shahidi, M; Temple, G; ... Plummer, R; + view all (2007) Activity of BIBW2992, an oral irreversible dual EGFR/HER2 inhibitor, in non-small cell lung cancer (NSCLC) with mutated EGFR. J THORAC ONCOL , 2 (8) S410 - S410.

Strauss, SJ; Higginbottom, K; Jüliger, S; Maharaj, L; Allen, P; Schenkein, D; Lister, TA; (2007) The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines. Cancer Res , 67 (6) pp. 2783-2790. 10.1158/0008-5472.CAN-06-3254.

T

Thirlwell, C; Howarth, KM; Segditsas, S; Guerra, G; Thomas, HJW; Phillips, RKS; Talbot, IC; ... Tomlinson, I; + view all (2007) Investigation of pathogenic mechanisms in multiple colorectal adenoma patients without germline APC or MYH/MUTYH mutations. BRIT J CANCER , 96 (11) 1729 - 1734. 10.1038/sj.bjc.6603789.

Tolner, B; Smith, L; Hillyer, T; Bhatia, J; Beckett, P; Robson, L; Sharma, SK; ... Chester, KA; + view all (2007) From laboratory to Phase I/II cancer trials with recombinant biotherapeutics. EUR J CANCER , 43 (17) 2515 - 2522. 10.1016/j.ejca.2007.08.027.

Toumpanakis, C; Quigley, A; Srirajaskanthan, R; Karpathakis, A; Krepska, A; Davidson, A; Meyer, T; ... Caplin, ME; + view all (2007) The new radiolabelled somatostatin analogue 90Yttrium-dota-octreotate for the treatment of metastatic neuroendocrine tumors: Initial results and tolerability in a series of 47 patients. In: (Proceedings) Annual Meeting of the British-Society-of-Gastroenterology. (pp. A42-A43). B M J PUBLISHING GROUP

V

Von, MG; Vogel, P; Schmidt, M; Eidtmann, H; Cufer, T; De Jongh, F; Maartense, E; ... Loibl, S; + view all (2007) Trastuzumab treatment beyond progression in patients with HER-2 positive metastatic breast cancer - the TBP study (GBG 26/BIG 3-05). In: (pp. S185-S185).

W

Whelan, J; Smeland, S; Marina, N; Bernstein, M; Sydes, MR; Butterfass-Bahoul, T; Perisoglou, M; ... Bielack, S; + view all (2007) Successful pan-European and trans-Atlantic collaboration in a randomised controlled trial in osteosarcoma: EURAMOS1 (ISRCTN67613327; a trial conducted as part of ECTEUROCORES). In:

Whelan, J; Smeland S, MN; Bernstein M, SM; May E, B-BT; Perisoglou M, CD; Calaminus G, MR; Hogendoorn P, UB; (2007) Successful trans-Atlantic collaboration in a randomised controlled trial in osteosarcoma: EURAMOS1 (ISRCTN67613327; a trial conducted as part of ECT-EUROCORES) – a potential model for collaboration in rare diseases. In:

Whelan, J; Sydes, M; Bielack, S; Smeland, S; Marina, N; May, E; Butterfass-Bahloul, T; ... Bernstein, M; + view all (2007) Successful trans-Atlantic collaboration in a randomised controlled trial in osteosarcoma: EURAMOS1 (ISRCTN67613327; a trial conducted as part of ECT-EUROCORES) – a potential model for collaboration in rare diseases. In:

Whelan, JLI; Nooij M, SM; Grimer R, HP; Memon M, WS; Uscinska B, VGM; Kirkpatrick A, HE; Craft A, TOBOTMRCBO06AEORTC80931CAEOI; (2007) Intensified chemotherapy improved histological response but not survival in patients with operable osteosarcoma of an extremity: results of a randomised phase III study of the European Osteosarcoma Intergroup (MRC BO06 80931 ISRCTN86294690). Journal of the National Cancer Institute , 99 pp. 112-128.

Wilkins, D; Mayer, A; Sharma, S; Tolner, B; Springer, C; Hartley, J; Boxer, G; ... Begent, R; + view all (2007) Interim Results of a Phase I/II Trial of Antibody Directed Enzyme Prodrug Therapy (ADEPT) in Patients with Gastrointestinal Carcinoma. In: (Proceedings) NCRI Cancer Conference Proceedings.

Wood, K; Saunders, MI; Honess, DJ; Maxwell, RJ; Wilson, J; Paul, RL; Marsden, PK; ... Blower, PJ; + view all (2007) Evaluation of the effects of blood flow on 64Cu-ATSM distribution in a rodent tumour model. In: (Proceedings) International Meeting on Innovative Approaches in Head and Neck Oncology. (pp. S35-S36). ELSEVIER IRELAND LTD

Wylie, JP; Mandall, P; Bottomley, D; Hoskin, PJ; (2007) Multi-institutional UK prostate brachytherapy database. In: (pp. S50-S51).

This list was generated on Sun May 20 01:52:19 2018 BST.